BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2991321)

  • 21. Proglucagon processing in a rat islet cell line resembles phenotype of intestine rather than pancreas.
    Philippe J; Mojsov S; Drucker DJ; Habener JF
    Endocrinology; 1986 Dec; 119(6):2833-9. PubMed ID: 3536450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
    Drucker DJ; Asa SL; Silverberg J; Brubaker PL
    Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo and in vitro degradation of glucagon-like peptide-2 in humans.
    Hartmann B; Harr MB; Jeppesen PB; Wojdemann M; Deacon CF; Mortensen PB; Holst JJ
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2884-8. PubMed ID: 10946898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular forms of human enteroglucagon in tissue and plasma: plasma responses to nutrient stimuli in health and in disorders of the upper gastrointestinal tract.
    Ghatei MA; Uttenthal LO; Christofides ND; Bryant MG; Bloom SR
    J Clin Endocrinol Metab; 1983 Sep; 57(3):488-95. PubMed ID: 6874888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating and tissue forms of the intestinal growth factor, glucagon-like peptide-2.
    Brubaker PL; Crivici A; Izzo A; Ehrlich P; Tsai CH; Drucker DJ
    Endocrinology; 1997 Nov; 138(11):4837-43. PubMed ID: 9348213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do glucagonomas always produce glucagon?
    Wewer Albrechtsen NJ; Challis BG; Damjanov I; Holst JJ
    Bosn J Basic Med Sci; 2016 Feb; 16(1):1-7. PubMed ID: 26773171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and structural characterization of proglucagon-derived peptides, pancreatic polypeptide, and somatostatin from the urodele Amphiuma tridactylum.
    Cavanaugh ES; Nielsen PF; Conlon JM
    Gen Comp Endocrinol; 1996 Jan; 101(1):12-20. PubMed ID: 8713640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of a pancreatic tumor containing vasoactive intestinal peptide, neurotensin, and pancreatic polypeptide.
    Shulkes A; Boden R; Cook I; Gallagher N; Furness JB
    J Clin Endocrinol Metab; 1984 Jan; 58(1):41-8. PubMed ID: 6315763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of glucagon-like peptide-1(7-36) amide in rat brain.
    Yoshimoto S; Hirota M; Ohboshi C; Shima K
    Ann Clin Biochem; 1989 Mar; 26 ( Pt 2)():169-71. PubMed ID: 2729860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular localization of proglucagon/glucagon-like peptide I messenger RNAs in rat brain.
    Han VK; Hynes MA; Jin C; Towle AC; Lauder JM; Lund PK
    J Neurosci Res; 1986; 16(1):97-107. PubMed ID: 2427741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic proglucagon processing: isolation and structures of glucagon and glucagon-like peptide from gene I.
    Nichols R; Lee TD; Andrews PC
    Endocrinology; 1988 Dec; 123(6):2639-45. PubMed ID: 3058456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon-like peptide 1 immunoreactivity in gastroentero-pancreatic endocrine tumors: a light- and electron-microscopic study.
    Eissele R; Göke R; Weichardt U; Fehmann HC; Arnold R; Göke B
    Cell Tissue Res; 1994 Jun; 276(3):571-9. PubMed ID: 8062345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of glucagon-like peptide 1 (7-36) amide and glucagon on amylin release from perfused rat pancreas.
    Inoue K; Hisatomi A; Umeda F; Nawata H
    Horm Metab Res; 1991 Sep; 23(9):407-9. PubMed ID: 1743611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans.
    Orskov C; Rabenhøj L; Wettergren A; Kofod H; Holst JJ
    Diabetes; 1994 Apr; 43(4):535-9. PubMed ID: 8138058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor.
    Knudsen LB; Pridal L
    Eur J Pharmacol; 1996 Dec; 318(2-3):429-35. PubMed ID: 9016935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proglucagon processing in porcine and human pancreas.
    Holst JJ; Bersani M; Johnsen AH; Kofod H; Hartmann B; Orskov C
    J Biol Chem; 1994 Jul; 269(29):18827-33. PubMed ID: 8034635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative peptidomics of the endocrine pancreas: islet hormones from the clawed frog Xenopus laevis and the red-bellied newt Cynops pyrrhogaster.
    Conlon JM; Kim JB; Johansson A; Kikuyama S
    J Endocrinol; 2002 Dec; 175(3):769-77. PubMed ID: 12475387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".
    Recant L; Perrino PV; Bhathena SJ; Danforth DN; Lavine RL
    Diabetologia; 1976 Aug; 12(4):319-26. PubMed ID: 183997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impaired intestinal proglucagon processing in mice lacking prohormone convertase 1.
    Ugleholdt R; Zhu X; Deacon CF; Ørskov C; Steiner DF; Holst JJ
    Endocrinology; 2004 Mar; 145(3):1349-55. PubMed ID: 14630721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.